| |
| |
|
| Insider
Information: |
Babu Yarlagadda S |
| Relationship: |
Chief Discovery Officer |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
298,541 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,883,794 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
298,541 |
|
|
| Total
Value |
$1,883,794 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -66.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Discovery Officer |
2022-11-14 |
298,541 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2021-12-07 |
4 |
S |
$12.20 |
$367,220 |
D/D |
(30,100) |
215,056 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2021-12-07 |
4 |
OE |
$4.73 |
$293,260 |
D/D |
62,000 |
245,156 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
250,056 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2022-03-07 |
4 |
S |
$17.16 |
$343,200 |
D/D |
(20,000) |
230,056 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2022-11-14 |
4 |
OE |
$1.42 |
$142,000 |
D/D |
100,000 |
330,056 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Discovery Officer |
• • – |
2022-11-14 |
4 |
S |
$13.88 |
$437,428 |
D/D |
(31,515) |
298,541 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2014-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
206,630 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2014-02-24 |
4 |
D |
$12.20 |
$99,674 |
D/D |
(8,170) |
221,639 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2014-02-24 |
4 |
OE |
$4.30 |
$99,670 |
D/D |
23,179 |
229,809 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2014-03-01 |
4 |
D |
$11.69 |
$18,914 |
D/D |
(1,618) |
220,021 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2014-03-04 |
4 |
S |
$12.57 |
$510,870 |
D/D |
(40,642) |
208,195 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2014-03-04 |
4 |
OE |
$4.30 |
$241,177 |
D/D |
28,816 |
248,837 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,900 |
217,095 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-01-01 |
4 |
D |
$12.16 |
$29,208 |
D/D |
(2,402) |
214,693 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-01-20 |
4 |
D |
$11.17 |
$48,724 |
D/D |
(4,362) |
210,331 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$16,667 |
D/D |
(1,634) |
208,697 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-04 |
4 |
S |
$10.50 |
$110,198 |
D/D |
(10,495) |
198,202 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-05 |
4 |
S |
$10.59 |
$396,066 |
D/D |
(37,400) |
160,802 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2015-03-19 |
4 |
S |
$10.16 |
$122,987 |
D/D |
(12,105) |
148,697 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$16,914 |
D/D |
(1,639) |
147,058 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$35,666 |
D/D |
(4,724) |
142,334 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$1,930 |
D/D |
(906) |
141,428 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2016-08-25 |
4 |
S |
$4.06 |
$121,800 |
D/D |
(30,000) |
111,428 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$10,375 |
D/D |
(1,639) |
109,789 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - Drug Discovery |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$30,244 |
D/D |
(5,083) |
104,706 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
